Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Mucolytic + Expectorant + Decongestant
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Productive cough with nasal congestion
- Acute bronchitis with congestion
- Cough associated with cold or flu
- Sinusitis with productive cough
- Post-URI persistent productive cough
Mechanism of Action
Ambroxol breaks down acid mucopolysaccharide fibres in mucus and stimulates surfactant production by alveolar type-II cells. Guaifenesin increases respiratory tract fluid volume, reducing mucus viscosity. Phenylephrine vasoconstricts nasal mucosa via alpha-1 adrenergic activation.
Dosage & Administration
- Adults: 1 tablet three times daily for 5–7 days.
- Take with plenty of fluids to enhance expectoration.
Side Effects
- Nausea, GI upset, dry mouth, palpitations, insomnia (Phenylephrine).
- Rare hypersensitivity reactions.
Contraindications
- Hypersensitivity to any component.
- Severe hypertension or coronary disease.
- MAOI use within 14 days.
- Severe hepatic or renal impairment.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet?
MRPs range from ₹790 to ₹790 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Ambroxol (60 mg) + Guaifenesin (50 mg) + Phenylephrine (5 mg) + Paracetamol (325 mg) + Cetirizine (2.5 mg) Tablet?